The Digest’s 2026 Multi-Slide Guide to Corbion

Corbion has launched its “BRIGHT 2030” strategy, pivoting toward fermentation-based natural preservation and nutrition while initiating a strategic review of its PLA portfolio. The company highlights its leadership in algae-derived omega-3 oils, securing long-term aquaculture contracts and expanding into nutraceuticals. Commercial highlights include double-digit growth in biomedical polymers driven by the UZEDY® partnership with MedinCell. New financial targets aim for 3-6% annual organic sales growth and ~18% adjusted EBITDA margins by 2028.